1. Home
  2. Analysis
  3. Prograf
  4. Difficulty-in-walking

Prograf and Difficulty in walking - a phase IV clinical study of FDA data

Summary:

Difficulty in walking is reported as a side effect among people who take Prograf (tacrolimus), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Prednisone, and have Osteoporosis.

The phase IV clinical study analyzes which people have Difficulty in walking when taking Prograf. It is created by eHealthMe based on reports of 41,725 people who have side effects when taking Prograf from the FDA, and is updated regularly.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

What is Difficulty in walking?

Difficulty in walking is found to be associated with 731 drugs and 977 conditions by eHealthMe. Check the latest studies of Difficulty in walking.

On Jul, 21, 2026

41,725 people reported to have side effects when taking Prograf.
Among them, 34 people (0.08%) have Difficulty in walking.

Could Prograf cause Difficulty in walking?

Among these 34 people:

How long have people been on Prograf when they have Difficulty in walking? *

  • < 1 month: 20 %
  • 1 - 6 months: 40 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 20 %
  • 5 - 10 years: 20 %
  • 10+ years: 0.0 %

What is the gender of people who have Difficulty in walking when taking Prograf? *

  • female: 31.25 %
  • male: 68.75 %

What is the age of people who have Difficulty in walking when taking Prograf? *

  • 0-1: 0.0 %
  • 2-9: 3.85 %
  • 10-19: 11.54 %
  • 20-29: 19.23 %
  • 30-39: 23.08 %
  • 40-49: 19.23 %
  • 50-59: 19.23 %
  • 60+: 3.85 %

What are other drugs people take besides Prograf? *

  1. Prednisone: 16 people, 47.06%
  2. Cellcept: 9 people, 26.47%
  3. Prednisolone: 8 people, 23.53%
  4. Klonopin: 5 people, 14.71%
  5. Famotidine: 4 people, 11.76%
  6. Mycelex: 4 people, 11.76%
  7. Mycophenolate Mofetil: 4 people, 11.76%
  8. Clotrimazole: 3 people, 8.82%
  9. Omeprazole: 3 people, 8.82%
  10. Ganciclovir: 3 people, 8.82%

What are other side effects people have besides Difficulty in walking? *

  1. Weakness: 10 people, 29.41%
  2. Joint Pain: 5 people, 14.71%
  3. Myopathy (a muscular disease in which the muscle fibres do not function): 4 people, 11.76%
  4. Mood Swings (an extreme or rapid change in mood): 4 people, 11.76%
  5. Oral Pain: 3 people, 8.82%
  6. Fall: 3 people, 8.82%
  7. Oedema Mouth (swelling of mouth): 3 people, 8.82%
  8. Speech Impairment (Adult) (inability to speak (adult)): 3 people, 8.82%
  9. Bone Marrow Oedema (inflammation that causes much than the needed fluid in a bone): 2 people, 5.88%
  10. Dysstasia (difficulty in standing): 2 people, 5.88%

What are the existing conditions these people have? *

  1. Pain: 1 person, 2.94%
  2. Osteoporosis (bones weak and more likely to break): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and have Difficulty in walking?

- Check whether Difficulty in walking is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prograf:

Difficulty in walking treatments and more:

How severe was Difficulty in walking and when was it recovered:

Expand to all the drugs that have ingredients of tacrolimus:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Difficulty in walking:

Browse all the conditions that are associated with Difficulty in walking:

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Prograf) and Prograf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.